Anne Kwakman

Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment

D. de Jong, B. Ylstra, J. Zijlstra, 2022, HemaSphere.

Exploring the predictive potential of programmed death ligand 1 expression in healthy organs and lymph nodes as measured by 18F-BMS-986192 PET: pooled analysis of data from four solid tumor types

G. Hospers, A. D. de Langen, R. van de Ven, 2024, Journal for ImmunoTherapy of Cancer.